Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 163.32% is 325% above its 5-year average of -72.59%, around the middle of its 5-year range (-173.28%–688.20%).
3.53% above its 12-month average of 157.75%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -2.50%.
NET PROFIT MARGIN
163.32%
NET PROFIT MARGIN AVG TTM
157.75%
NET PROFIT MARGIN AVG 3Y
-42.34%
NET PROFIT MARGIN AVG 5Y
-72.59%
NET PROFIT MARGIN AVG 10Y
-71.55%
NET PROFIT MARGIN AVG 15Y
-50.35%
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+3.53%
CURRENT VS 3Y AVG
+485.75%
CURRENT VS 5Y AVG
+324.98%
CURRENT VS 10Y AVG
+328.25%
CURRENT VS 15Y AVG
+424.35%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+62915.38%
vs the sector median at left
Fortress Biotech, Inc.
Market Cap
$146.27M
Net Profit Margin
163.32%
TTM Avg
157.75%
3Y Avg
-42.34%
5Y Avg
-72.59%
Market Cap
$146.28M
Net Profit Margin
-39.55%
TTM Avg
-86.23%
3Y Avg
-76.35%
5Y Avg
-60.08%
Market Cap
$146.62M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-85.02%
Market Cap
$148.27M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$148.64M
Net Profit Margin
-312.63%
TTM Avg
-188.89%
3Y Avg
-109.57%
5Y Avg
-101.19%
Market Cap
$143.84M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$148.73M
Net Profit Margin
-353.00%
TTM Avg
-161.48%
3Y Avg
-3791.01%
5Y Avg
-3351.38%
Market Cap
$143.60M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$149.36M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-644.95%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fortress Biotech, Inc. (FBIOP) | $146.27M | 163.32% | 157.75% | -42.34% | -72.59% |
| Codexis, Inc. (CDXS)vs › | $146.28M | -39.55% | -86.23% | -76.35% | -60.08% |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $146.62M | 0.00% | 0.00% | 0.00% | -85.02% |
| Anavex Life Sciences Corp. (AVXL)vs › | $148.27M | 0.00% | 0.00% | 0.00% | 0.00% |
| Voyager Therapeutics, Inc. (VYGR)vs › | $148.64M | -312.63% | -188.89% | -109.57% | -101.19% |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $143.84M | 0.00% | 0.00% | 0.00% | 0.00% |
| Korsana Biosciences, Inc. (KRSA)vs › | $148.73M | -353.00% | -161.48% | -3791.01% | -3351.38% |
| Protara Therapeutics, Inc. (TARA)vs › | $143.60M | 0.00% | 0.00% | 0.00% | 0.00% |
| ALX Oncology Holdings Inc. (ALXO)vs › | $149.36M | 0.00% | 0.00% | 0.00% | -644.95% |
| Nyxoah S.A. (NYXH)vs › | $143.10M | -435.70% | -1104.64% | -1053.90% | -4200.61% |
Operating Margin
-111.0%
Net Profit Margin
163.3%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -2.50% |
| 2026-03-31 | 688.20% |
| 2025-12-31 | -24.49% |
| 2025-09-30 | 33.18% |
| 2025-06-30 | 94.35% |
| 2025-03-31 | -80.55% |
| 2024-12-31 | -44.74% |
| 2024-09-30 | -87.96% |
| 2024-06-30 | -73.50% |
| 2024-03-31 | -118.32% |
| 2023-12-31 | -46.52% |
| 2023-09-30 | -14.52% |
| 2023-06-30 | -142.51% |
| 2023-03-31 | -173.28% |
| 2022-12-31 | -164.28% |
| 2022-09-30 | -136.20% |
| 2022-06-30 | -113.08% |
| 2022-03-31 | -65.87% |
| 2021-12-31 | -172.71% |
| 2021-09-30 | -98.56% |
| 2021-06-30 | -19.81% |
| 2021-03-31 | -76.14% |
| 2020-12-31 | -38.51% |
| 2020-09-30 | -164.08% |
| 2020-06-30 | -140.78% |
| 2020-03-31 | -95.76% |
| 2019-12-31 | -139.19% |
| 2019-09-30 | -130.60% |
| 2019-06-30 | -141.60% |
| 2019-03-31 | 21.49% |
| 2018-12-31 | 15.94% |
| 2018-09-30 | -26.12% |
| 2018-06-30 | -33.85% |
| 2018-03-31 | -37.92% |
| 2017-12-31 | -22.98% |
| 2017-09-30 | -57.83% |
| 2017-06-30 | -34.25% |
| 2017-03-31 | -26.82% |
| 2016-12-31 | -138.18% |
| 2016-09-30 | -1331.38% |
| 2016-06-30 | -559.55% |
| 2016-03-31 | -1849.24% |
| 2015-12-31 | -3560.95% |
| 2015-09-30 | -72644.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | -2411.20% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |